Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 7, 2024Scientific ReportsOpen Access

Synthesis, anticancer activity, and molecular docking of half-sandwich iron(II) cyclopentadienyl complexes with maleimide and phosphine or phosphite ligands

View Full Paper
Ask AI
Bookmark
Share

Authors

SDSujoy DasMSMarcelina StrachanowskaPWPiotr Wadowski

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Das et al. (2024) studied this question.

synapsesocial.com/papers/68e75433b6db6435876cc385https://doi.org/10.1038/s41598-024-56339-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Exploration of the Anticancer Efficacy and In Silico Drug Screening Study of Fe(II) and Fe(III) Complexes of Schiff Base and Phenanthroline Ligand2026
  2. 2Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer Agents2024 · 10 citations
  3. 3Isocyanide Incorporation Expands the Anticancer Potential of Diiron(I) Aminocarbyne Complexes2026 · 4 citations
  4. 4Diiron(I) Complexes with Promising Anticancer Properties Obtained by CO-To-Isocyanide Substitution of [Fe2Cp2(CO)4]2026
  5. 51,3,5-Triaza-7-phosphaadamantane and Cyclohexyl Groups Impart to Di-Iron(I) Complex Aqueous Solubility and Stability, and Prominent Anticancer Activity in Cellular and Animal Models2024 · 11 citations